Molecular determinants of dihydrouridine synthase activity  by Savage, Dan F. et al.
FEBS Letters 580 (2006) 5198–5202Molecular determinants of dihydrouridine synthase activity
Dan F. Savagea, Vale´rie de Cre´cy-Lagardb, Anthony C. Bishopa,*
a Department of Chemistry, Amherst College, Amherst, MA 01002, USA
b Department of Microbiology and Cell Science, University of Florida, P.O. Box 110700, Gainesville, FL 32611-0700, USA
Received 31 May 2006; revised 20 July 2006; accepted 14 August 2006
Available online 5 September 2006
Edited by Lev KisselevAbstract Dihydrouridine is one of the most abundant modiﬁed
bases in tRNA. However, little is known concerning the biochem-
istry of dihydrouridine synthase (DUS) enzymes. To identify
molecular determinants that are necessary for DUS activity,
we have developed a DUS-complementation assay in Escherichia
coli. Using this assay, we have identiﬁed amino-acid residues that
are critical for the activity of YjbN, an E. coli DUS. We also
show that the aq1598 gene product, a putative DUS from Aqui-
fex aeolicus, catalyzes dihydrouridine formation, providing the
ﬁrst biochemical demonstration that A. aeolicus encodes an ac-
tive DUS.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transfer RNA is the central adapter molecule in translation,
as it provides the physical link between the genetic information
of messenger RNA and the addition of correctly ordered
amino acids to a growing polypeptide chain. One of the struc-
tural hallmarks of tRNA is the presence of a wide variety of
post-transcriptionally modiﬁed RNA bases [1]. More than 90
diﬀerent modiﬁcations have been identiﬁed [2,3] (30–50 can
be found in a given organism [4]) and each tRNA isoacceptor
has a particular modiﬁcation pattern [1]. Dihydrouridine is one
of the most abundant modiﬁed tRNA bases in prokaryotes
and eukaryotes [1]. It diﬀers from uridine only by the reduction
of uridine’s carbon-carbon double bond (Fig. 1), and is found
predominantly in the D-loop of tRNA, which can contain
varying numbers of dihydrouridine residues. (The tRNA mol-
ecules of, for instance, Escherichia coli contain up to four
dihydrouridine residues with the vast majority containing at
least one [1].) Despite its widespread occurrence, little is known
about dihydrouridine’s roles in mediating tRNA function. The
most likely chemical role of dihydrouridine is to enhance theAbbreviations: DUS, dihydrouridine synthase; DHODH, dihydrooro-
tate dehydrogenase; DHPDH, dihydropyrimidine dehydrogenase;
FMN, ﬂavin mononucleotide
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doi:10.1016/j.febslet.2006.08.062conformational ﬂexibility of tRNA [5,6]. However, the biolog-
ical ramiﬁcations of this increased ﬂexibility are unclear.
The family of dihydrouridine synthase (DUS) enzymes,
which catalyze the modiﬁcation of uridine to dihydrouridine,
has been identiﬁed in Saccharomyces cerevisiae and E. coli
[7,8]. DUSs comprise a discrete gene family, allowing putative
DUS genes from other organisms to be proposed based on
sequence homology. However, little is known concerning DUS
biochemistry. No previous studies have described the regions
of DUS enzymes that give rise to their activity, speciﬁcity, or
mechanism of action.
The goal of the current work is to elucidate the biochemical
determinants that are necessary for DUS activity. Toward this
end, our attempts at developing an in vitro activity assay for
the three E. coli DUSs (YjbN, YhdG, and YohI) have not,
to date, been successful, presumably due to a combination of
two factors: protein instability (we have observed precipitation
of puriﬁed DUSs) and incorrect choice of tRNA substrate (the
tRNA speciﬁcity of the individual E. coli DUSs is not known).
To circumvent these technical hurdles, we have developed an
in vivo DUS-complementation assay. Utilizing an E. coli strain
from which all three DUS genes have been deleted (D3dus),
and, consequently, produces tRNA with no detectable
dihydrouridine, we have reconstituted the tRNA’s dihydrouri-
dine content through reintroduction of plasmid-borne DUS
genes. The dihydrouridine-free strain thus acts as a ‘‘blank
slate’’ for testing the ability of mutant DUS genes, or putative
DUS genes, to catalyze dihydrouridine formation in living
cells. Measurement of the dihydrouridine levels in tRNA puri-
ﬁed from the reconstituted strains gives a direct readout of the
DUS capability of the introduced gene. We have applied this
complementation scheme to mutant E. coli DUSs, as well as
a putative DUS from the thermophilic bacterium Aquifex
aeolicus, allowing us to identify amino-acid residues that are
critical for DUS activity, and to unambiguously assign DUS
activity to a biochemically uncharacterized gene.2. Materials and methods
2.1. Strain and plasmid construction
2.1.1. D3dus. The construction of the E. coli D3dus strain has been
described previously [8].
2.1.2. YjbN-expressing plasmids. The yjbN gene was ampliﬁed from
E. coli (MG1655) genomic DNA using the following primers (5 0–3 0):
ATAACATAACCCCATGATATATCG and ACGGTGCGC-
AGGGCGTGGTGAATTTG. The resulting PCR product was in-
serted into pPCR4-topo (Invitrogen), according to the manufacturer’s
instructions, to give pVDC597. Digestion of pVDC597 with EcoRI,
yielded a 1.1 kb fragment which was ligated into EcoRI-digested
pVDC521 (a slightly modiﬁed version of pBAD18 [9]) yieldingblished by Elsevier B.V. All rights reserved.
Fig. 2. Reconstitution of dihydrouridine in E. coli tRNA through
genetic complementation. An E. coli strain containing no genomic
DUSs (D3dus) was transformed with empty vector or a vector
containing yjbN. The strains were grown with the indicated concen-
trations of glucose (G) or arabinose (A), and their tRNA as harvested.
The dihydrouridine content of 80 lg tRNA from each sample was
quantiﬁed as described in Section 2. The right bar indicates the
equivalent experiment performed with a double-DUS-knockout strain
(DyhdG/DyohI) that harbors genomic yjbN as its sole DUS gene.
Fig. 1. Chemical structures of uridine and dihydrouridine.
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using the Quikchange mutagenesis kit (Stratagene) according to the
manufacturer’s guidelines. The sequences of the eleven sets of muta-
genic primers can be found in ‘‘Supplementary material’’ (Table S1).
After mutagenesis, the DNA products were transformed into DH5a
and selected on LB-agar/ampicillin. Plasmid DNA from individual
ampicillin-resistant colonies was harvested. Introduction of the desired
mutations was conﬁrmed by sequencing over the YjbN-coding region
(Biotechnology Resource Center, Cornell University). Mutant plas-
mids were heat transformed into D3dus, and plasmid-harboring colo-
nies were selected on LB-agar/ampicillin/chloramphenicol.
2.1.3. Aq1598-expressing plasmid (pVDC581). The aq1598 gene
was ampliﬁed from A. aeolicus genomic DNA using the following
primers (5 0–3 0): GCGCCATGGACTTCAAAAAGGGAGAGGTA-
ATTC and GCGAAGCTTTTAGTCGACGGCATAAAGTAATT-
CCCTCTCCTTCG. (Addition of 10% DMSO to the PCR mixture
was necessary for eﬃcient ampliﬁcation.) The resulting PCR product
was doubly digested with NcoI and HindIII, gel puriﬁed, and inserted
into NcoI/HindIII-digested pBAD24 [9].
2.2. tRNA preparation
Two ml of saturated E. coli cultures were diluted into 250 ml LB
(supplemented with the appropriate antibiotics and glucose or arabi-
nose concentration) and harvested during late log phase growth
(OD600  0.8–1.0). Frozen cell pellets were resuspended in 7 ml re-sus-
pension buﬀer (0.3 M sodium acetate, 10 mM EDTA, pH 5.2) and ex-
tracted twice with buﬀer-saturated phenol (pH 4.3). The aqueous layer
was collected and total RNA was precipitated with ethanol. The tRNA
was puriﬁed on a Nucleobond AX-500 column (Clontech) according to
the manufacturer’s protocol, precipitated with isopropanol, washed
with 80% ethanol, and re-dissolved in RNase-free water. Concentra-
tions of tRNA samples were assessed by measuring their respective
A260 values.
2.3. Total dihydrouridine assay
Colorimetric measurement of dihydrouridine content in tRNA con-
tent was performed essentially as described [8,10,11] (also see ‘‘Supple-
mentary material’’ for a detailed protocol.) Bars and error bars in Figs.
2–4 represent the average (A550–A465) values and standard deviations,
respectively, derived from at least three independent experiments.3. Results
3.1. Reconstitution of E. coli YjbN activity
It has not previously been shown that DUS activity can be
reconstituted in an organism that lacks dihydrouridine. To
investigate complementation as a means of evaluating DUS
activity, we cloned yjbN, a DUS-encoding gene from E. coli
[8], into a plasmid carrying an arabinose-inducible promoter
(pBAD18). Introduction of the resulting plasmid (pVDC205)
into D3dus gave rise to substantial tRNA-dihydrouridine for-
mation (Fig. 2). The YjbN-produced dihydrouridine contentwas found to be independent of arabinose concentration,
and reached maximum levels even in the absence of arabinose
or in the presence of glucose, an expression repressor (Fig. 2).
The reintroduced dihydrouridine levels (regardless of arabi-
nose concentration) are also comparable to that of a previ-
ously described double-DUS-knockout strain (DyhdG/DyohI)
[8] that harbors genomic yjbN as its sole DUS gene. These
results suggest that, for wild-type YjbN, tRNA-dihydro-
uridine levels are essentially independent of the enzyme
concentration in a cell, as the population of highly YjbN-
expressing cells increases at high arabinose concentrations
[12]. (See Figure S1 in ‘‘Supplementary material’’ for a dem-
onstration of arabinose-dependent YjbN overexpression.)
Moreover, the presence of full-dihydrouridine content in the
absence of arabinose, implies that even low levels of active
YjbN are suﬃcient to completely modify YjbN’s cellular tar-
gets.
3.2. DUS activity of YjbN mutants
To identify residues that are for critical DUS activity
in E. coli, and, potentially, in DUS enzymes from other
Fig. 3. Design and analysis of YjbN mutants. (A) Partial sequence alignment of the three E. coliDUSs (YjbN, YhdG, and YohI) with human DUS2
(hDUS2). Positions that are conserved among the four DUSs, but not mutated in the current work, are marked with asterisks. Mutated YjbN
residues are highlighted and numbered. (B) and (C) DUS activity of YjbN mutants. The indicated YjbN mutants were introduced into D3dus, and the
resulting strains were grown in 0.02% arabinose (B) or in the absence or arabinose (C). Puriﬁcation of tRNA samples and dihydrouridine
quantiﬁcation (80 lg tRNA) for panels B and C was carried out as described in the legend of Fig. 2 and Section 2.
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into yjbN. Our mutational analysis was guided by a primary
sequence alignment of four DUSs: the three E. coli DUSs,
and a human DUS, hDUS2, that has been implicated in pul-
monary carcinogenesis (Fig. 3A) [13]. Only 22 positions are
conserved among these four DUSs, and from these we selected
eight yjbN positions for mutation (N111, C114, P115, K153,
R155, H186A, R188, R249, Fig. 3A). (We avoided hydropho-
bic residues and glycine residues. An exception: P115, which
was mutated, as it lies in the most highly conserved region of
DUSs.) Among our mutational positions are the only four
positions that are rigorously conserved in a more extensive
alignment of 64 putative DUSs from various organisms:
N111, C114, K153, and R155. Additionally, R27 and E57 of
YjbN were mutated, as these residues are conserved in the
three E. coli DUSs, if the alignment is performed without
hDUS2 (not shown). A total of eleven mutants at ten positions
were constructed and introduced into D3dus (the one conserved
DUS cysteine residue, C114, was replaced with both serine and
alanine).
We harvested tRNA from each of the mutant DUS-express-
ing strains and analyzed the tRNA samples for dihydrouridine
content (Fig. 3B). We found that YjbN activity is surprisingly
resilient to mutation when the mutant-expressing strains are
grown in the presence of arabinose (0.02%). Nine of the eleven
YjbN mutants retained substantial DUS activity, while twomutants (C114A and K153A) produced tRNA with no detect-
able dihydrouridine (Fig. 3B).
Among the mutants that retained signiﬁcant DUS activity
when grown in the presence of 0.02% arabinose were
N111A, R155A, H186A, and R188A YjbN. These results were
somewhat unexpected, as N111 and R155 are two of the four
residues that are rigorously conserved among DUSs, and H186
and R188 are also strongly conserved. All four of these amino
acids are also predicted to lie in the active site of DUSs (see
Section 4). We hypothesized that the observed activity of these
mutants may be an artifact of overexpression. To test this idea,
we re-grew these strains in media that lacked arabinose, and
puriﬁed the resulting tRNA. In contrast to wild-type YjbN,
whose DUS-complementation level is arabinose-independent
(Fig. 2), N111A, R155A, H186A, and R188A YjbN all pro-
duce no detectable dihydrouridine when grown in the absence
of arabinose (Fig. 3C). Most likely, these four mutants have
substantial catalytic deﬁciencies, which preclude detectable
dihydrouridine formation at low enzyme-expression levels.
These deﬁciencies can be overcome in vivo, however, through
protein overexpression (Fig. 3B).
3.3. DUS activity of Aq1598
Although putative DUS genes can be readily identiﬁed
through sequence homology, few DUSs have been biochemi-
cally conﬁrmed. DUS complementation may provide a rapid
Fig. 4. DUS activity of Aq1598. (A) Partial sequence alignment of
E. coli YjbN and Aq1598. Activity-determining residues, as identiﬁed
in the experiments shown in Fig. 3 are highlighted. (B) E. coli strain
D3dus was transformed with empty vector, a vector containing yjbN, or
a vector containing aq1598. The resulting strains were grown in the
presence of 0.02% arabinose, and their tRNA was harvested. The
dihydrouridine content of each sample (150 lg of tRNA) was
quantiﬁed as described in the legend of Fig. 2 and Section 2.
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genes, including genes from organisms that have not been
shown to contain dihydrouridine. To test this idea, we intro-
duced aq1598 from A. aeolicus into D3dus E. coli. The
aq1598 gene encodes a putative DUS that possesses all six of
the amino acid residues that we found to be required for
wild-type-like YjbN activity (N93, C96, K138, R140, H166,
R168 in Aq1598 numbering, Fig. 4A). As shown in Fig. 4B,
Aq1598-expressing E. coli cells do, indeed, produce dihydro-
uridine, when grown in the presence of arabinose (0.02%).Fig. 5. Proposed locations of catalytically important YjbN residues. (A) The
a ribbon diagram in magenta (PDB: 1VHN) [14]. The sidechains of N111, C1
an active-site-bound sulfate ion are shown as sticks. Atom coloring is by elem
sulfur. (B) Partial sequence alignment of E. coliYjbN and TM0096. Activity-d
highlighted. (C) A close-up representation of the DUS active site. Atomic
according to E. coli YjbN.However, the aq1598 gene product gives rise to substantially
lower amounts of dihydrouridine than does E. coli YjbN.
(Due to the lower dihydrouridine content of Aq1598-modiﬁed
tRNA, 150 lg of tRNA, instead of 80 lg, was used, as a means
to increase the signal-to-noise ratio of the assay.) The low
dihydrouridine content of Aq1598-expressing cells is presum-
ably due to a combination of speciﬁcity (Aq1598 may only rec-
ognize a subset of E. coli tRNAs) and activity (Aq1598 has
been transferred from a thermophilic organism into a meso-
philic one, and it presumably has non-optimal kinetic param-
eters with E. coli tRNA substrates). Our results demonstrate
that A. aeolicus does encode an active DUS. Moreover, mod-
iﬁcation of E. coli tRNAs by the aq1598 gene product provides
the ﬁrst example of cross-species DUS activity.4. Discussion
We have developed a DUS-complementation assay that has
allowed us to identify six amino acids that are necessary for
YjbN’s full in vivo catalytic activity. (While it is possible that
these mutations disrupt activity through a trivial mechanism,
such as disruption of protein folding, this scenario is unlikely,
as all six mutants express eﬃciently as soluble 6-His-tagged
constructs and can be puriﬁed at wild-type levels. See Figure
S2 of ‘‘Supplementary material.’’) Due to the strong conserva-
tion of the activity-determining residues across the DUS
family, it is likely that they will control the activity of other
DUSs, as well. To better understand the role of these amino
acids, we have mapped them onto the three-dimensional struc-
ture of TM0096, a putative DUS from Thermotoga maritima,
which comprises a ﬂavin mononucleotide (FMN)-binding
a/b-barrel domain in addition to a C-terminal 4-helix bundle
(Fig. 5A) [14]. (No structure of a biochemically conﬁrmed
DUS has been reported.) When aligned with TM0096
(Fig. 5B), all six of YjbN’s catalytically important residues
lie in the putative active site of the a/b barrel; and all six are
within 6 A˚ of the bound FMN molecule (Fig. 5C). Together,three-dimensional structure of the putative DUS, TM0096, is shown as
14, K153, R155, H186, R188 are shown as balls and sticks. FMN and
ent: gray for carbon, red for oxygen, blue for nitrogen, and yellow for
etermining residues, as identiﬁed in the experiments shown in Fig. 3 are
rendering and coloring are as in panel A. Amino-acid numbering is
5202 D.F. Savage et al. / FEBS Letters 580 (2006) 5198–5202these six residues make up a large fraction of the FMN-bind-
ing catalytic site.
Previous work from other families of oxidoreductases allows
us to speculate further regarding the catalytic role of one of
YjbN’s critical residues, C114. Our data from the C114S and
C114A YjbN mutants show that an amino acid capable of
acid/base (or, less likely, nucleophilic) catalysis is necessary
at position 114 for DUS activity: a serine mutation at 114 is
tolerated, but the alanine mutant is devoid of detectable activ-
ity. These ﬁndings are analogous to previous studies on homol-
ogous enzymes that catalyze similar redox chemistry, namely
the dihydroorotate dehydrogenases (DHODHs) and dihydro-
pyrimidine dehydrogenases (DHPDHs) [15–18]. Both of these
families are weakly homologous to the DUSs, and each pos-
sesses a conserved cysteine that aligns with C114 of YjbN.
Mutagenic and kinetic data have pinpointed this conserved
cysteine as a key general-acid/base catalyst in both DHODHs
and DHPDHs [17,18]. (Interestingly, the catalyst is a serine
residue in one DHODH family [19].) Our data suggest that
C114 is likely to play a similar role in the DUS-catalyzed reac-
tion.
One of the fascinating and outstanding questions regarding
DUS function is that of tRNA speciﬁcity. Previous work has
shown that E. coli DUSs have non-overlapping tRNA sub-
strates [8], and that the DUSs of S. cerevisiae act speciﬁcally
on particular D-loop positions [20]. However, this cannot be
the case for all organisms. For example, the Mycoplasma
mycoides genome encodes only a single DUS, yet its tRNA
contains multiple modiﬁcation sites [1,21]. Moreover, our cur-
rent results show that the speciﬁcity of a DUS is not limited to
the corresponding tRNAs of its natural host—DUS activity
can be readily transferred from A. aeolicus to E. coli. The bio-
chemical means by which DUSs are able to achieve this deli-
cate balance between promiscuity and speciﬁcity of tRNA
target remains to be explored.
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